Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG890 Levonorgestrel Patch PK and Wearability Study
NCT01623466Phase 2Completed
- Sponsor
- Agile Therapeutics
- Start
- Jul 2012
- Primary completion
- Sep 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of AG890 in contraception, sponsored by Agile Therapeutics. Primary endpoint: Levonorgestrel Pharmacokinetic Profile at 8 weeks. Started Jul 2012; status: completed.
02
Drugs
AG890
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01623466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623466.